Merriman Curhan Ford Hires Veteran Biotechnology Analyst Edward H. Nash
* Reuters is not responsible for the content in this press release.
SAN FRANCISCO--(Business Wire)-- Merriman Curhan Ford Group, Inc. (NASDAQ:MERR) today announced that it has hired Edward H. Nash as a senior biotechnology equity research analyst and managing director. Nash will be based out of the New York office. "Edward brings a high level of experience and seniority to our firm as we aggressively revamp our health care practice," said Jon Merriman, chief executive officer of Merriman Curhan Ford. "His background is a great fit for our platform, and his skill set also complements Panel Intelligence, our primary market research subsidiary. I am very pleased to welcome him to the firm." Nash brings more than 10 years of experience as a biotechnology analyst. Most recently he was a senior biotech analyst and equity research principal at Stifel, Nicolaus & Co. Prior to Stifel he was a biotech analyst at several firms, including Rodman & Renshaw, Commerce Capital Markets, Ladenburg Thalmann & Co. and Lazard Freres & Co. He holds an M.B.A. and an M.S. from the University of Miami and an M.P.H. from the University of Alabama at Birmingham. About Merriman Curhan Ford Merriman Curhan Ford (NASDAQ:MERR) is a financial services firm focused on fast-growing companies and the institutions who invest in them. The company offers high-quality investment banking, equity research, institutional services, primary market research, corporate & executive services, asset management and venture services, and specializes in four growth industry sectors: CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. For more information, please go to www.mcfco.com. Note to Investors This press release contains certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. Forward-looking statements in this release are based on information available to us as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business, which include the risk factors disclosed in our Form 10-Q filed on August 11, 2008. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will," and "would" or similar words. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise. The Form 10-Q filed on August 11, 2008, together with this press release and the financial information contained herein, is available on our website by going to www.mcfco.com and clicking on "Investor Relations." Mandelbaum Partners Shawn Simmons, 310-785-0810 shawn@mandelbaumpartners.com Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters